The Council of European Bioregions (CEBR) is a European network bringing together around 50 health clusters, including Eurobiomed.
For this exclusive webinar, CEBR is partnering with the European Medicines Agency (EMA) to present the regulatory support tools available to developers of innovative medicines and health technologies.
Join us to hear directly from the EMA, gain first-hand insights into their support mechanisms, and ask your questions live to their experts.
You’ll hear from two key speakers from the EMA who will share their expertise and insights:
- Hélène Casaert – Scientific Officer, EMA
Hélène is a Scientific Officer within the SME Office, where she provides dedicated support to small and medium-sized enterprises developing medicines in the EU and fosters innovation across the sector.
Before joining the EMA, she worked as a Regulatory Affairs Manager in the pharmaceutical industry and in the clinical trials division of the French national competent authority.
- Sebastian Asprella – Programme Lead, EMA
Sebastian leads EU competitiveness initiatives at the EMA, focusing on predictable, science-based regulatory pathways that help clusters, tech transfer offices, and SMEs translate European scientific excellence into tangible patient benefits.
